-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-256-telehealth-women-disposition-comments.pdf
June 16, 2022 - In one study, all
participants were pregnant women who were patients at an academic health
center.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/multiple-sclerosis_executive.pdf
April 01, 2015 - 1
Comparative Effectiveness Review
Number 150
Decisional Dilemmas in Discontinuing
Prolonged Disease-Modifying Treatment for
Multiple Sclerosis
Executive Summary
Background
Multiple sclerosis (MS) is a variably
debilitating disease characterized by
demyelination (deterioration of the
protective myelin sheat…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments.pdf
December 23, 2023 - Comparator
Placebo
No treatment
Usual care
Other, specify ______________
• Population
Pregnant … women
Elderly (65 years and older)
Children & adolescents (up to 18 years old)
Co-morbidities
-
effectivehealthcare.ahrq.gov/products/headaches-pregnancy/research
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
August 01, 2012 - specific
populations was updated
(pregnancy: topamax can
cause fetal harm when
administered to a pregnant … women); and the counseling
information concerning eye
disorders was updated
The published critique … change for
topamax (topiramate)
specifying that it can cause
fetal harm when
administered to a pregnant … woman, and the benefits and
risks should be considered
when administering the drug
in women of childbearing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
August 01, 2012 - specific
populations was updated
(pregnancy: topamax can
cause fetal harm when
administered to a pregnant … women); and the counseling
information concerning eye
disorders was updated
The published critique … change for
topamax (topiramate)
specifying that it can cause
fetal harm when
administered to a pregnant … woman, and the benefits and
risks should be considered
when administering the drug
in women of childbearing
-
effectivehealthcare.ahrq.gov/health-topics/diabetes-and-pregnancy
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-sepsis.pdf
July 01, 2023 - affected by sepsis, though certain groups
such as neonates, young children, pregnant or recently-pregnant … women, older persons
and individuals with underlying chronic conditions are at an elevated risk.2
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
January 01, 2020 - Whole-Body Vibration Therapy for Osteoporosis
Whole-Body Vibration
Therapy for Osteoporosis
Technical Brief
Number 10
Technical Brief
Number 10
Whole-Body Vibration Therapy for Osteoporosis
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 G…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-generated-health-data-protocol-chronic-conditions.pdf
March 17, 2020 - EXCLUDE:
Individuals with other
conditions, pregnant
women, post-partum
women.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
December 01, 2017 - We excluded studies in pregnant women, and restricted our
synthesis to treatments currently available
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/child-growth-development-outcomes-protocol-amended.pdf
November 18, 2024 - Dietary Total Fat Intake and Dietary Polyunsaturated Fatty Acid Intake and Child Growth and Development Outcomes: A Systematic Review
Evidence-based Practice Center Systematic Review Protocol
Project Title: Dietary Total Fat Intake and Dietary Polyunsaturated Fatty Acid
Intake and Child Growth and Develop…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonopioid-pharm-chronic-pain-protocol.pdf
February 01, 2019 - Nonopioid Pharmacologic Treatments for Chronic Pain
Evidence-based Practice Center Systematic Review Protocol
Project Title: Nonopioid Pharmacologic Treatments for Chronic Pain
I. Background and Objectives for the Systematic Review
Understanding Chronic Pain
Chronic pain is typically defined as pain l…
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/child-growth-development-outcomes-protocol.pdf
August 19, 2024 - Dietary Total Fat Intake and Dietary Polyunsaturated Fatty Acid Intake and Child Growth and Development Outcomes: A Systematic Review
Evidence-based Practice Center Systematic Review Protocol
Project Title: Dietary Total Fat Intake and Dietary Polyunsaturated Fatty Acid
Intake and Child Growth and Develop…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breastfeeding_research-protocol.pdf
January 01, 2020 - Inform all pregnant women about the benefits and management of breastfeeding.
4.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/missing-data-registries-guide-3rd-ed-addendum-white-paper.pdf
February 01, 2018 - observable for a later start of follow-up.”3 For example, in a study of
miscarriage which enrolls pregnant … women, some patients will be left truncated because “an
unknown proportion of the source population … leading the study
sample to not accurately reflect the underlying target population, in this example, pregnant … women at risk for miscarriage.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-206-evidence-summary-sodium-potassium.pdf
June 01, 2018 - Evidence-Summary-CER-206-Sodium-And-Potassium-Intake-Effects-On-Chronic-Disease-Outcomes-And-Risk
Comparative Effectiveness Review
Number 206
Sodium and Potassium Intake: Effects on
Chronic Disease Outcomes and Risks
Evidence Summary
Background and Objectives
Cardiovascular disease (CVD) and kidney
disease1 ar…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
March 01, 2013 - 1
Comparative Effectiveness Review
Number 96
Primary Care Management
of Abnormal Uterine Bleeding
Executive Summary
Background
Abnormal uterine bleeding (AUB) is
among the most common gynecologic
complaints of reproductive-age women
in ambulatory care settings. It is estimated
to affect 11 to 13 percent of…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/child-growth-development-outcomes-draft-report-rob.xlsx
January 01, 2017 - No No Yes Yes Yes Yes Low No - the effect of a reduction in the n26:n23 LCPUFA ratio in the diet of pregnant … women and breastfeeding mothers on adipose tissue growth in
their infants up to 1 y of age.
14488 Brantsaeter
-
effectivehealthcare.ahrq.gov/products/mental-health-pregnancy/research